Professor Fukushima Addresses ‘A Tremendous Crisis’ of Vaccine Related Harm

By NZDSOS September 12, 2023

Professor Masanori Fukushima first reached international attention in November 2022 when he attended an extraordinary session in the House of Representatives in Tokyo to challenge the Japanese Ministry of Health on the harms their interventions were causing. As an oncologist, pharmaco-epidemiologist, clinical trials and regulatory affairs scientist Professor Fukushima joins the growing number of qualified professionals with highly relevant experience who have been sounding the alarm about the dangers of the medical products unleashed onto populations worldwide.

Most recently Professor Fukushima has been named the representative director of the Japanese Society for Vaccine Related Complications (JSVRC), launched with medical, science and legal colleagues associated with various academic and private institutions in Japan. The JSVRC held a one hour press conference at the Ministry of Health on 7 September 2023, which is available here in Japanese. Thanks go to @shortshort_news on Twitter for this two minute English transcript of Professor Fukushima addressing the media. The video and transcript are below.

NZDSOS stand with Professor Fukushima and his colleagues, in denouncing the pharmaceutical products which are causing grave harm to populations, and calling for all physicians and scientists to begin immediately collaborating to address this crisis. This must be done in a way that ensures this can never happen again.

Join NZDSOS on 16 September at our first public conference, to learn more about our work and the collaborations being formed within and beyond New Zealand. In-person attendance is sold out, but online tickets are available here. If you are joining us for the event, we look forward to seeing you there.

https://lionessofjudah.substack.com/p/professor-fukushima-addresses-a-tremendous?utm_source=post-email-title&publication_id=581065&post_id=137028340&utm_campaign=email-post-title&isFreemail=true&r=o554c&utm_medium=email

Leave a Reply